CA2475821C - Group b streptococcus antigens - Google Patents

Group b streptococcus antigens Download PDF

Info

Publication number
CA2475821C
CA2475821C CA2475821A CA2475821A CA2475821C CA 2475821 C CA2475821 C CA 2475821C CA 2475821 A CA2475821 A CA 2475821A CA 2475821 A CA2475821 A CA 2475821A CA 2475821 C CA2475821 C CA 2475821C
Authority
CA
Canada
Prior art keywords
polypeptide
ala
amino acid
val
thr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2475821A
Other languages
English (en)
French (fr)
Other versions
CA2475821A1 (en
Inventor
Denis Martin
Josee Hamel
Bernard R. Brodeur
Stephane Rioux
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
ID Biomedical Corp of Quebec
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ID Biomedical Corp of Quebec filed Critical ID Biomedical Corp of Quebec
Publication of CA2475821A1 publication Critical patent/CA2475821A1/en
Application granted granted Critical
Publication of CA2475821C publication Critical patent/CA2475821C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Dermatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA2475821A 2002-02-11 2003-02-11 Group b streptococcus antigens Expired - Fee Related CA2475821C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US35494702P 2002-02-11 2002-02-11
US60/354,947 2002-02-11
PCT/CA2003/000186 WO2003068813A2 (en) 2002-02-11 2003-02-11 Group b streptococcus antigen

Publications (2)

Publication Number Publication Date
CA2475821A1 CA2475821A1 (en) 2003-08-21
CA2475821C true CA2475821C (en) 2011-12-13

Family

ID=27734441

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2475821A Expired - Fee Related CA2475821C (en) 2002-02-11 2003-02-11 Group b streptococcus antigens

Country Status (8)

Country Link
US (1) US20070275004A1 (https=)
EP (1) EP1472353B1 (https=)
JP (1) JP2005535287A (https=)
AT (1) ATE543906T1 (https=)
AU (1) AU2003203097C1 (https=)
CA (1) CA2475821C (https=)
ES (1) ES2381967T3 (https=)
WO (1) WO2003068813A2 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2540281T3 (es) 1998-02-20 2015-07-09 Id Biomedical Corporation Of Quebec Antígenos de estreptococos del grupo B
DK1328543T3 (da) 2000-10-27 2009-11-23 Novartis Vaccines & Diagnostic Nukleinsyrer og proteiner fra streptococcus-gruppe A & B
JP4875490B2 (ja) 2003-07-31 2012-02-15 ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド ＳｔｒｅｐｔｏｃｏｃｃｕｓＰｙｏｇｅｎｅｓについての免疫原組成物
US8945589B2 (en) 2003-09-15 2015-02-03 Novartis Vaccines And Diagnostics, Srl Immunogenic compositions for Streptococcus agalactiae
EP1784211A4 (en) 2004-07-29 2010-06-30 Novartis Vaccines & Diagnostic IMMUNOGENIC COMPOSITIONS FOR GRAMPOSITIVE BACTERIA SUCH AS STREPTOCOCCUS AGALACTIAE
WO2006086330A2 (en) * 2005-02-08 2006-08-17 Id Biomedical Corporation Of Quebec C.O.B. As Glaxosmithkline Biologicals North America Pharmaceutical compositions
ES2310062B1 (es) * 2005-07-15 2009-11-13 Bionostra, S.L. Particulas pseudovirales vacias quimericas derivadas del virus causante de la enfermedad de la bursitis infecciosa (ibdv), procedimiento de obtencion y aplicaciones.
CA2699513C (en) 2007-09-12 2018-03-13 Novartis Ag Gas57 mutant antigens and gas57 antibodies
CN103834669B (zh) * 2014-02-21 2016-06-29 通威股份有限公司 一种无乳链球菌的口服疫苗及其制备方法
CN107502622A (zh) * 2016-06-14 2017-12-22 广东省农业科学院动物卫生研究所 Sip基因重组载体、壳聚糖‑PLGA包裹Sip基因DNA疫苗及其制备方法和应用
CA3268712A1 (en) * 2018-06-13 2025-10-14 Gen-Probe Incorporated Compositions and Methods for Detecting Group B Streptococcus Nucleic Acid

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5302386A (en) * 1986-04-16 1994-04-12 Brigham And Women's Hospital, Inc. Bacterial antigens, antibodies, vaccines and methods of manufacture
US5472696A (en) * 1988-02-26 1995-12-05 Univ. Of Florida Research Foundation, Inc. Antigen of group B streptococci
US5648241A (en) * 1989-09-15 1997-07-15 The General Hospital Corporation Conjugate vaccine against group B streptococcus
US5679768A (en) * 1991-02-15 1997-10-21 Uab Research Foundation Epitopic regions of pneumococcal surface protein A
US5225331A (en) * 1991-04-25 1993-07-06 National Research Council Of Canada Immunoassay for detecting group b streptococcus
DK0656014T3 (da) * 1993-03-19 2003-08-11 Gunnar Lindahl Protein Rib, et celleoverfladeprotein der overfører immunitet mod mange gruppe B Streptococcus stammer, fremgangsmåde til oprensning af proteinet, reagenskit og farmaceutisk komposition
US5595740A (en) * 1994-05-16 1997-01-21 University Of Florida Cloning of non-IgA FC binding forms of the group B streptococcal beta antigens
CN1142229A (zh) * 1994-11-01 1997-02-05 麒麟麦酒株式会社 形成粘蛋白糖链的肽序列和修饰蛋白质使与粘蛋白糖链相连的方法
ES2540281T3 (es) * 1998-02-20 2015-07-09 Id Biomedical Corporation Of Quebec Antígenos de estreptococos del grupo B
GB9921125D0 (en) * 1999-09-07 1999-11-10 Microbial Technics Limited Proteins

Also Published As

Publication number Publication date
WO2003068813A3 (en) 2003-10-16
EP1472353A2 (en) 2004-11-03
EP1472353B1 (en) 2012-02-01
AU2003203097A1 (en) 2003-09-04
ATE543906T1 (de) 2012-02-15
CA2475821A1 (en) 2003-08-21
ES2381967T3 (es) 2012-06-04
AU2003203097B2 (en) 2009-10-01
JP2005535287A (ja) 2005-11-24
AU2003203097C1 (en) 2010-02-04
US20070275004A1 (en) 2007-11-29
WO2003068813A2 (en) 2003-08-21

Similar Documents

Publication Publication Date Title
EP2281891A2 (en) Streptococcus antigens
WO2003054007A2 (en) Streptococcus antigens
CA2475821C (en) Group b streptococcus antigens
JP5194199B2 (ja) グループｂ連鎖球菌の抗原及び対応するｄｎａ断片
US20080227706A1 (en) Bvh-a2 and bvh-a3 antigens of group b streptococcus
AU2002317107A1 (en) Group B streptococcus antigens and corresponding DNA fragments
EP1660660B1 (en) Pharmaceutical compositions for use in the treatment of Streptococcus Pyogenes infection
US20040171113A1 (en) Antigens of group b streptococcus and corresponding dna fragments
WO2004007725A1 (en) Polypeptide of streptococcus pyogenes

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20200211